J0174 HCPCS code: Lecanemab-irmb, for intravenous injection, 1 mg
J0174 is the HCPCS Level II code for lecanemab-irmb, for intravenous injection, 1 mg. In 2024 Medicare paid an average of $1.04 per service for J0174 across 41,743,052 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume rose 1763% from 2023 to 2024 (2,240,731 to 41,743,052 services). In 2024, about 1,233 clinicians billed Medicare for J0174 for 4,734 beneficiaries; Florida, Texas, New York accounted for 41% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-06 |
| Last action effective | 2026-04-01 |
Who bills J0174 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,233 |
| Medicare beneficiaries | 4,734 |
| States with claims | 39 |
| Share of services in top 3 states (Florida, Texas, New York) | 41% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0174, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 2,240,731 | 673 | $1.31 | $1.04 |
| 2024 | 41,743,052 | 4,734 | $1.30 | $1.04 |
States with the most J0174 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 9,798,591 | $1.03 |
| Texas | 4,644,330 | $1.04 |
| New York | 2,564,826 | $1.05 |
| California | 2,562,688 | $1.03 |
| South Carolina | 1,784,196 | $1.05 |
What changed for J0174
- April 2026: Descriptor revised (Was: Injection, lecanemab-irmb, 1 mg)
- 2023-07-06: J0174 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0174?
J0174 is the HCPCS Level II code for lecanemab-irmb, for intravenous injection, 1 mg. Short descriptor: "Lecanemab-irmb, for iv inj".
How much does Medicare pay for J0174?
In 2024, the average Medicare payment was $1.04 per service (average allowed $1.30).
Does Medicare cover J0174?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J01 codes
- J0120 — Injection, tetracycline, up to 250 mg
- J0121 — Injection, omadacycline, 1 mg
- J0122 — Injection, eravacycline, 1 mg
- J0129 — Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130 — Injection abciximab, 10 mg
- J0131 — Injection, acetaminophen, not otherwise specified,10 mg
- J0132 — Injection, acetylcysteine, 100 mg
- J0133 — Injection, acyclovir, 5 mg
- J0134 — Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg
- J0135 — Injection, adalimumab, 20 mg
- J0136 — Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
- J0137 — Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0174
- Watch J0174 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0174
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.